Notizie e Video - COHORT ORD 10P

Unique AI technology was selected for advances in solving the "last mile challenge." SAN RAMON, CA / ACCESS Newswire / March 19, 2025 / App Orchid , a leader in making data actionable with Artificial Intelligence (AI), today announced a partnership with Plug and Play , a leading innovation platform, connecting startups, corporations, venture capital firms, universities, and government agencies. This collaboration will harness Plug and Play's global network to scale App Orchid's customer-centric...

TransCode Therapeutics Announces Safety Review Committee Approval to Open Fourth Cohort in Phase I/II Clinical Trial PR Newswire BOSTON, March 13, 2025 Clinical trial Safety Review Committee (SRC) approved opening of Cohort 4 based on favorable safety data from the three patients comprising Cohort 3 No significant safety or dose limiting toxicities reported in Cohorts 1, 2, or 3 Patients currently being evaluated for Cohort 4 eligibility PK and PD data from patients in Cohort 1 and Cohort 2...

Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial PR Newswire SAN JOSE, Calif., Feb. 26, 2025 SAN JOSE, Calif. , Feb. 26, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced has it has dosed its final patient in the third cohort of its ongoing Phase 1 clinical trial evaluating its novel chimeric antigen...

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing CD19-targeted ARTEMIS ® T-cell therapies to treat cancer and autoimmune diseases, today announced the successful completion of the first dose cohort in its ongoing STARLIGHT-1 Phase I/II clinical trial. Following a review of safety and efficacy data, the Data and Safety Monitoring Board (DSMB) has approved the initiation of the second dose cohort, which...

TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial PR Newswire EDINBURGH, Scotland, Feb. 13, 2025 No adverse events related to TCB008 have occurred Evidence of stable disease following TCB008 infusion EDINBURGH, Scotland , Feb. 13, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today...

TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial PR Newswire EDINBURGH, Scotland, Feb. 10, 2025 First Cohort B patient received 4 doses (approx. 819 million Gamma Delta T-cells) Cohort B recruitment continues at multiple clinical sites across the United Kingdom EDINBURGH, Scotland , Feb. 10, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform...

TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial PR Newswire BOSTON, Feb. 6, 2025 No significant safety or dose limiting toxicities reported PK data from Cohorts 1 and 2 consistent with preclinical and Phase 0 trial results BOSTON , Feb. 6, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that Cohort 3...

BOSTON, MA / ACCESS Newswire / February 4, 2025 / MassRobotics , the largest independent robotics hub, welcomes the second cohort of the MassRobotics Accelerator , powered by the Massachusetts Technology Collaborative's (MassTech) Innovation Institute . Following a successful inaugural program, MassRobotics welcomes a diverse and dynamic second cohort that includes Haystack Ag , LiftLabs , Mito Robotics , Nexterity , p!ng , Redefine Surgery , ReviMo , Revolute Robotics , Tatum Robotics , and...

Nationwide cohort seeks to advance healthy, sustainable, and equitable school food reform. SACRAMENTO, CALIFORNIA / ACCESS Newswire / February 4, 2025 / The Chef Ann Foundation announced today that it has selected 27 school food leaders to participate in the 2025 Healthy School Food Pathway Fellowship . The Fellowship empowers school food professionals to lead healthier and more environmentally sustainable school food programs rooted in scratch cooking and champion equitable school food reform....

PHOENIX, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) , a clinical-stage biotechnology company focused on regenerative medicine, today announced promising initial data from the first cohort of its ongoing Phase 1/2 clinical trial of CELZ-201-DDT, the Company’s proprietary stem cell-based therapeutic for the treatment of chronic back pain caused by degenerative disc disease (DDD). The first cohort of 10 participants (8 receiving CELZ-201-DDT and 2...

Salv opens applications for Bridge cohort to protect customers from APP fraud and disrupt criminal networks PR Newswire LONDON, Jan. 16, 2025 Salv's next Bridge cohort will tackle cross-border APP fraud together, one of the fastest-growing financial crimes. Criminals exploit gaps in cross-border payment systems, using speed and fragmented regulations to steal funds. Salv Bridge connects financial institutions to close these gaps. Real-time collaboration stops fraud by protecting customers and...

TransCode Therapeutics Announces First Patient Dosed in Third Cohort with Lead Candidate in Phase 1 Clinical Trial PR Newswire BOSTON, Jan. 14, 2025 Follows Safety Review Committee (SRC) approval based on safety data from patients in Cohorts 1 and 2 No significant safety or dose limiting toxicities reported in Cohorts 1 and 2 PK data from Cohorts 1 and 2 consistent with preclinical and Phase 0 trial results BOSTON , Jan. 14, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the...

BOSTON, MA / ACCESSWIRE / January 9, 2025 / MassRobotics announces the fourth cohort of its Healthcare Robotics Startup Catalyst Program, marking a record-breaking year with an unprecedented number of applicants. This year's cohort includes six innovative companies selected for their cutting-edge solutions in healthcare robotics. The selection process was guided by the expertise and support of the MassRobotics Steering Committee, which includes industry leaders from MITRE, Festo, Mitsubishi...

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial PR Newswire BOSTON, Dec. 18, 2024 Approval given after Safety Review Committee (SRC) review of safety data from the three patients comprising Cohort 2 No significant safety or dose limiting toxicities reported in Cohort 2 New patients currently being evaluated for eligibility in Cohort 3 PK and PD data from Cohort 1 patients...

The program helps school districts serve fresher, healthier, made-from-scratch meals. BOULDER, COLORADO / ACCESSWIRE / December 17, 2024 / The Chef Ann Foundation announced today it has selected six K-12 school districts in five states to participate in the sixth cohort of its flagship program, Get Schools Cooking . Over the next three years, the Chef Ann Foundation will offer comprehensive support to help the districts make changes that enable them to transition from serving students...

Palantir Technologies Inc. (NASDAQ: PLTR) today announced its first Warp Speed cohort, comprised of companies committed to reindustrializing America’s manufacturing and production capabilities through advanced AI and technology. The inaugural members include: Anduril Industries, L3Harris, Panasonic Energy of North America (PENA), and Shield AI. Palantir’s Warp Speed is the manufacturing operating system that provides the speed, flexibility, and security required for the modern manufacturer....

WASHINGTON, DC / ACCESSWIRE / December 6, 2024 / Mission1st Group, Inc./Ardent , a leader in digital transformation, geospatial intelligence, and AI/ML for defense and national security, is proud to announce that Richard R. Zareck II, President and CEO has graduated from MissionLink , an exclusive nationwide network that serves as a force-multiplier and gateway to accelerating innovation and advancing solutions to National Security threats. Founded in 2010, MissionLink's mission is to connect...

Includes Faculty and Academic Staff from Higher Education Institutions in the US and Puerto Rico GRAND RAPIDS, MI / ACCESSWIRE / December 5, 2024 / Teach Access , a national nonprofit that bridges the digital accessible technology skills gap-a gap in accessibility knowledge and digital skills among students graduating and entering the workforce-is excited to announce its Fellowship Program 2025 cohort. The Teach Access Fellowship Program engages faculty and academic staff from higher education...

Avangrid, Inc. (NYSE: AGR), a leading sustainable energy company and member of the Iberdrola Group, today announced that the second cohort of newly hired technicians has graduated from Avangrid’s National Training Center (NTC). Technicians from Avangrid wind projects in three different states attended two-and-a-half weeks of safety and technical training at the NTC located in Sherman County, Oregon. This press release features multimedia. View the full release here:...

Oncolytics Biotech® Reports Completion of Initial Safety Phase Enrollment for GOBLET Trial's New Pancreatic Cancer Cohort PR Newswire SAN DIEGO and CALGARY, AB, Dec. 3, 2024 Early safety and tolerability results from six randomized patients support continued enrollment of pelareorep combined with modified FOLFIRINOX, with or without atezolizumab The study will begin with 30 patients, with an option to expand to an additional 34 participants SAN DIEGO and CALGARY, AB , Dec. 3, 2024 /PRNewswire/...